PharmaShots | Incisive News in 3 Shots

Subscribe Now

Transfusion-Dependent Thalassemia

Bluebird Bio's Zynteglo Receives CHMP's Positive Opinion for Conditional Marketing for Patients with Transfusion-Dependent β-Thalassemia (TDT) without β0/β0 Genotype

Bluebird Bio's Zynteglo Receives CHMP's Positive Opinion for Conditional Marketing for Patients with Transfusion-Dependent β-Thala...

April 1, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us